Literature DB >> 34563104

Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine.

Felice Crocetto1, Amelia Cimmino2, Matteo Ferro3, Daniela Terracciano4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34563104     DOI： 10.1515/jbcpp-2021-0233

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN： 0792-6855


× No keyword cloud information.
  6 in total

Review 1.  Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges.

Authors:  Hiu Ting Chan; Yoon Ming Chin; Siew-Kee Low
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

Review 2.  Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives.

Authors:  Felice Crocetto; Gianluca Russo; Erika Di Zazzo; Pasquale Pisapia; Benito Fabio Mirto; Alessandro Palmieri; Francesco Pepe; Claudio Bellevicine; Alessandro Russo; Evelina La Civita; Daniela Terracciano; Umberto Malapelle; Giancarlo Troncone; Biagio Barone
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

Review 3.  Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review.

Authors:  Biagio Barone; Armando Calogero; Luca Scafuri; Matteo Ferro; Giuseppe Lucarelli; Erika Di Zazzo; Enrico Sicignano; Alfonso Falcone; Lorenzo Romano; Luigi De Luca; Francesco Oliva; Benito Fabio Mirto; Federico Capone; Ciro Imbimbo; Felice Crocetto
Journal:  Cancers (Basel)       Date:  2022-05-21       Impact factor: 6.575

4.  MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590.

Authors:  Chia-Chang Wu; Yuan-Hung Wang; Su-Wei Hu; Wen-Ling Wu; Chi-Tai Yeh; Oluwaseun Adebayo Bamodu
Journal:  Front Oncol       Date:  2022-01-13       Impact factor: 6.244

5.  OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.

Authors:  Jiaxing Lin; Xiao Xu; Tianren Li; Jihang Yao; Meng Yu; Yuyan Zhu; Dan Sun
Journal:  Front Oncol       Date:  2021-11-15       Impact factor: 6.244

Review 6.  Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review.

Authors:  Dai Koguchi; Kazumasa Matsumoto; Izuru Shiba; Takahiro Harano; Satoshi Okuda; Kohei Mori; Shuhei Hirano; Kazuki Kitajima; Masaomi Ikeda; Masatsugu Iwamura
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.